•
Dec 31, 2013

Cocrystal Pharma Q4 2013 Earnings Report

Total Revenue
-$5.76M
Previous year: $2.47M
-333.4%
EPS
-$0.21
Previous year: -$0.06
+250.0%
Cash and Equivalents
$1.03M
Previous year: $4.72M
-78.1%
Free Cash Flow
-$1.61M
Previous year: -$1.64M
-2.1%
Total Assets
$1.66M
Previous year: $7.24M
-77.1%

Cocrystal Pharma

Cocrystal Pharma